Hurwa

Beijing Hurwa Technology, known by its brand HURWA, pioneered China’s first domestically developed knee joint surgical robot to receive NMPA approval. The company emerged from Peking Union Medical College Hospital’s orthopedic department under the guidance of Professor Jin Lin, combining clinical expertise with robotics engineering to address the growing demand for precision joint replacement surgery.

Company Overview

Founded in January 2018 within the Beijing Economic-Technological Development Area, Hurwa operates at the intersection of medical robotics, software algorithms, and orthopedic surgery. The company’s founding team brings together academicians, medical professors, and specialists in robotics, image processing, and artificial intelligence.

On January 6, 2020, Hurwa achieved a significant milestone when Beijing Peking Union Medical College Hospital completed the first robot-assisted total knee arthroplasty using the company’s self-developed HURWA system. This procedure marked the first time a domestically manufactured knee surgical robot was used clinically in China, breaking the monopoly of imported products in this specialized field.

The company listed on China’s National Equities Exchange and Quotations (NEEQ, also known as New Third Board) in June 2023 under ticker 873940, reaching the Innovation Layer. In December 2023, Hurwa initiated the guidance filing process for a potential listing on the Beijing Stock Exchange.

Core Products

HURWA KRobot-5800

The first-generation knee joint surgical robot received NMPA Class III medical device registration in January 2022, becoming China’s first independently developed and approved knee replacement surgical robot. The system features a semi-autonomous robotic arm based on the KUKA LBR Med platform, integrated with infrared camera tracking and CT-based preoperative planning.

HURWA KHRobot-6800

Building upon the first-generation platform, the KHRobot-6800 expanded indications to cover total knee arthroplasty (TKA), total hip arthroplasty (THA), and femoral/tibial osteotomy procedures. This system received initial NMPA approval in May 2023, with additional spine surgery indications approved in June 2024. The KHRobot-6800 represents China’s first orthopedic surgical robot to cover knee replacement, hip replacement, and spinal procedures within a single platform.

Technology and Innovation

Hurwa’s robotic systems employ an open-platform architecture compatible with prostheses from multiple manufacturers including MicroPort, Smith & Nephew, Johnson & Johnson, Kingnow, and Akmedical. This contrasts with closed-system competitors that require proprietary implants.

Clinical studies published in peer-reviewed journals demonstrate bone resection accuracy below 0.5mm with angular deviation under 0.5 degrees. The learning curve for surgeons ranges from 8 to 16 cases depending on prior experience with robotic surgery.

The company’s intellectual property portfolio includes 159 authorized patents (42 invention patents) and 54 software copyrights as of December 2024, with an additional 75 patent applications pending.

Market Presence

According to company disclosures, Hurwa’s robotic systems have been installed in over 110 hospitals across China. The platform has supported more than 2,200 surgical procedures with over 2,000 surgeon training experiences completed.

The company has earned multiple recognitions including Beijing “Specialized and Sophisticated” SME designation, National High-tech Enterprise status, and Zhongguancun High-tech Enterprise certification. Hurwa was also named among China’s Top 20 Innovative Medical Devices and Future Healthcare 100.

Key Milestones

• 2018: Company founded in Beijing Economic-Technological Development Area
• 2020: First domestic robot-assisted TKA surgery at Peking Union Medical College Hospital
• 2022: HURWA KRobot-5800 receives NMPA approval (China’s first domestic knee robot)
• 2023: KHRobot-6800 approved for knee and hip replacement; NEEQ listing completed
• 2024: Spine surgery indication added to KHRobot-6800

Frequently Asked Questions

What products does Hurwa offer?

Hurwa manufactures orthopedic surgical robots under the HURWA brand. The product line includes the KRobot-5800 for knee replacement surgery and the KHRobot-6800 for orthopedic procedures covering knee, hip, and spine surgery. The company also provides supporting consumables and surgical technical service management systems.

Is Hurwa publicly traded?

Hurwa is listed on China’s NEEQ (New Third Board) under stock code 873940 since June 2023. The company is in the Innovation Layer and has initiated guidance procedures for a potential Beijing Stock Exchange listing.

How does HURWA compare to imported orthopedic robots?

HURWA systems employ an open-platform design compatible with multiple prosthesis brands, unlike some imported systems that require proprietary implants. Published clinical data shows comparable bone cutting accuracy (under 0.5mm deviation) to international systems. The domestic robot typically offers cost advantages for Chinese hospitals facing budget constraints.